U.S. Other Utilities Stock News

Hamilton Lane (NasdaqGS:HLNE) has launched a new Credit Income Fund targeting private credit exposure for a broader investor base. The firm has converted its Private Infrastructure Fund to an interval fund structure, with access now also available in tokenized form through Republic's digital platform. These changes expand access to private credit and infrastructure for private wealth and other non institutional investors. Hamilton Lane, trading at $94.84, is reshaping how investors can...

How WisdomTree’s recent performance frames today’s investment debate WisdomTree (WT) has drawn fresh investor attention after a strong year to date, with the stock showing a positive return and trailing twelve month performance that contrasts with pressure in the past week. For context, the shares are up about 31% year to date and roughly 90% over the past year, while the past week and past month have been mixed, with a 6% decline over seven days and a gain over the month. See our latest...

Oracle has reportedly canceled a major contract with Super Micro Computer, linked to an export-control indictment involving the company’s co founder. The loss of this contract is estimated to affect revenue by about $1.1b to $1.4b, with additional pressure from regulatory scrutiny and legal challenges. Relationships with key customers such as xAI also appear to be under strain, adding to concerns about future business activity. For investors tracking Super Micro Computer (NasdaqGS:SMCI),...

MercadoLibre (MELI) is back in focus after a mix of broker downgrades, record revenue growth data and sizable institutional selling highlighted the tension between its heavy investment plans and current profitability. See our latest analysis for MercadoLibre. MercadoLibre’s share price has been volatile, with an 11.94% 1 month share price return contrasted by a 14.13% 3 month decline and a 17.55% drop in 1 year total shareholder return. This reflects tension between heavy investment, margin...

nLIGHT (LASR) has drawn fresh attention after a sharp share price surge alongside recent quarterly results, even as muted revenue growth, cash burn, and declining returns on capital raise questions about how durable this momentum might be. See our latest analysis for nLIGHT. At a share price of US$75.79, nLIGHT has delivered very strong recent momentum, with a 90 day share price return of 72.52%, year to date share price return of 97.52%, and a 1 year total shareholder return that is many...

Investors may be wondering whether Intuitive Surgical, at around US$482 per share, still offers good value or if most of the opportunity is already priced in. The stock has recently moved 2.8% over the last week and 2.6% over the last month, while year to date it is down 14.2% and the 1 year return sits at a 6.3% decline, compared with a 60.1% return over 3 years and 67.2% over 5 years. Recent coverage has focused on how Intuitive Surgical fits into longer term themes in medical technology...

HubSpot (HUBS) has pushed further into AI with its Spring 2026 Spotlight, rolling out HubSpot AEO, an expanded Prospecting Agent, Smart Deal Progression, and an updated Customer Agent as investors watch the stock’s recent pullback. See our latest analysis for HubSpot. Despite the fresh AI product launches and upcoming first quarter 2026 results, HubSpot’s share price return has been weak over longer periods. The 30 day share price return shows a 6.2% decline and the 1 year total shareholder...

If you are wondering whether Knight-Swift Transportation Holdings is still attractively priced after a strong run, the starting point is understanding how its current share price lines up against different measures of value. The stock recently closed at US$65.20, with returns of 1.2% over 7 days, 15.7% over 30 days, 24.8% year to date, 70.0% over 1 year, 20.3% over 3 years and 46.3% over 5 years. These returns can change how the market views both its potential and its risks. Recent coverage...

Gaming and Leisure Properties (GLPI) opened 2026 with Q1 revenue of US$420 million and basic EPS of US$0.82, while trailing twelve month EPS reached US$3.17 and net income came in at US$891 million with a 55% net margin. Over the past year, revenue has moved from US$1.55 billion to US$1.62 billion and trailing basic EPS has gone from US$2.83 to US$3.17, alongside earnings growth of 15% and an increase in net margin from 50% to 55%. Together with trailing funds from operations of about US$1.11...

Dickies and Harley-Davidson announced in April 2026 that they reunited for a second limited-edition “Built to Outlast” apparel collection, now available on both brands’ online stores and select Harley-Davidson dealerships. The renewed capsule extends Harley-Davidson’s reach beyond motorcycles into lifestyle workwear, reinforcing the brand’s cultural relevance with younger and apparel-focused consumers. Next, we’ll examine how this renewed Dickies collaboration, and its focus on lifestyle...

Packaging Corporation of America (NYSE:PKG) reported strong first quarter operational performance, with record corrugated shipments in its legacy operations despite cost and weather headwinds. The company highlighted progress integrating Greif’s containerboard business, including efficiency gains across the Packaging segment. PCA outlined substantial annual synergy targets from the Greif integration and is implementing significant price increases in its packaging business. Packaging...

Rapport Therapeutics recently reported Phase 2a follow-up data for its investigational epilepsy drug RAP-219 in drug-resistant focal onset seizures, showing sustained reductions in both long episodes and clinical seizures over a 16-week period with generally favorable tolerability. An intriguing aspect of the update is RAP-219’s longer-than-previously-estimated 22-day half-life, which appears to maintain therapeutic receptor occupancy and seizure control well beyond the initial 8-week dosing...

Earlier this week, TJ Biopharma announced a definitive agreement under which Biogen will acquire its exclusive Greater China rights to felzartamab for up to US$850 million, giving Biogen worldwide control of the Phase 3 anti-CD38 antibody and responsibility for future development, manufacturing, and commercialization in the region. This deal consolidates felzartamab under one owner across multiple immune-mediated diseases and multiple myeloma in China, tightening the link between Biogen’s...

SiriusPoint recently received an upgrade from S&P Global Ratings, which raised the financial strength ratings of its core insurance subsidiaries to ‘A’ and the holding company rating to ‘BBB+,’ citing a stronger capital position, consistent underwriting results, and a lower-risk underwriting and investment profile. This higher credit profile could broaden SiriusPoint’s access to capital and counterparties, potentially reinforcing confidence in its underwriting platform and balance sheet...

Why Group 1 Automotive Is On Investors’ Radar Today Group 1 Automotive (GPI) has attracted fresh attention after recent trading left the stock with mixed return patterns, including a loss over the past 3 months but a gain over the past month. See our latest analysis for Group 1 Automotive. The recent 1 month share price return of 4.45% contrasts with a 3 month share price decline of 12.89% and a 1 year total shareholder return loss of 15.60%. This suggests that momentum has started to...

Avatier launched an auto enrolled, air gapped Multi Factor Authentication solution called the Identity Challenge Card after a recent cyberattack disrupted Stryker's identity systems. The card operates without smartphones, apps, or internet connectivity, aiming to keep authentication running when traditional identity tools are offline. The development is being watched as part of broader efforts to support operational resilience and business continuity in healthcare. Stryker (NYSE:SYK) enters...

Intellia Therapeutics (NasdaqGM:NTLA) plans to announce topline results from the first Phase 3 trial of an in vivo CRISPR gene editing candidate for hereditary angioedema. The upcoming readout will be the first-ever Phase 3 data release for an in vivo CRISPR therapy. The results are expected to be highly relevant for Intellia's future plans and for gene editing drug development more broadly. Intellia Therapeutics, trading at around $13.63, sits at the center of attention as it approaches a...

Earlier this week, ServiceNow reported first-quarter 2026 results with revenue of US$3.77 billion and modestly higher earnings, while also updating guidance and detailing margin headwinds linked to its Armis acquisition. A key development was ServiceNow’s deepened AI alliance with Google Cloud and new autonomous workflow wins such as TridentCare, underscoring how AI agents and unified data governance are increasingly embedded across its platform and customer base. We’ll now examine how...

In the first quarter of 2026, GE Aerospace reported revenue of US$12,392 million versus US$9,935 million a year earlier, with net income easing to US$1,904 million while basic EPS from continuing operations edged up to US$1.85. Alongside this, GE Aerospace continued sizeable share repurchases under its 2024 authorization and faced a US$36 million ITAR-related civil penalty, highlighting both active capital returns and ongoing compliance remediation. We’ll now examine how strong revenue...

Cintas Corporation previously announced that its Board of Directors approved a quarterly cash dividend of US$0.45 per share, payable on June 15, 2026, to shareholders of record as of May 15, 2026, extending a 42-year streak of annual dividend increases since its 1983 IPO. This latest dividend decision, alongside a history of consistently raising payouts, highlights Cintas’ ongoing emphasis on returning capital to shareholders as a core element of its business model. Next, we’ll examine how...

Everforth’s recent share slide Everforth (ASGN) has seen its share price under pressure, with the stock down about 52% over the past month and 63% over the past 3 months, drawing attention to its current valuation. See our latest analysis for Everforth. The recent 52% 7 day share price decline and 59% year to date share price return continue a longer trend, with a 63% 1 year total shareholder return loss pointing to fading momentum as investors reassess Everforth’s risk and growth profile. If...

Wondering if Sysco at around US$76.56 is still a fair deal or starting to look expensive? This article breaks down what the current share price might be implying about the company. Over shorter periods, the stock has been mixed, with a 0.4% return over 7 days, a 7.5% decline over 30 days, a 5.4% gain year to date, and 11.0% over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on Sysco's role in the food distribution sector,...

D.R. Horton, Inc. recently reported fiscal second-quarter 2026 results, with sales of US$7,365.3 million and net income of US$647.9 million, alongside updated full-year revenue guidance of US$33.5 billion to US$34.5 billion, a US$0.45 per share dividend declaration, and completion of a US$3.29 billion share repurchase program covering 7.77% of shares. While revenue and earnings were lower than a year earlier, management pointed to double-digit growth in net sales orders, reduced unsold...

Kratos Defense & Security Solutions (NasdaqGS:KTOS) completed initial flights of its Mk1 Firejet unmanned aerial system, powered by a new U.S.-made J85 engine. The company is scaling production of this engine to meet growing global demand for advanced, lower cost, high-performance military drone platforms. The Mk1 Firejet is positioned as a first to market American engineered tactical drone aimed at addressing pressing inventory needs for the U.S. and allies. Kratos comes into this Mk1...